Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating a combination therapy of HAIC, sintilimab, and bevacizumab for advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: TACE Combined With Lenvatinib and Sintilimab for Advanced HCC [Phase 2]
Phase 2 trial update evaluating the combination of TACE with lenvatinib and sintilimab for non-resectable hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Regorafenib Plus Sintilimab vs. Regorafenib as the Second-line Treatment for HCC [Phase 2]
A Phase 2 clinical trial comparing regorafenib plus sintilimab versus regorafenib alone as second-line therapy for non-resectable hepatocell…
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC [Phase 3]
Phase 3 trial comparing lenvatinib plus I-125 seed brachytherapy versus lenvatinib alone for TACE-refractory hepatocellular carcinoma (non-r…
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: HEPAR Primary: Holmium-166-radioembolization in Hepatocellular Carcinoma Patients [Phase 2]
Phase 2 trial update for Holmium-166 radioembolization (HEPAR Primary) in patients with hepatocellular carcinoma, including non-resectable d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy [Phase 2]
Phase 2 trial evaluating erlotinib plus bevacizumab as second-line therapy for hepatocellular carcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase Ib/II trial evaluating safety and efficacy of QL1706 in patients with advanced hepatocellular carcinoma is ongoing and status is unkno…
-
CLINICAL_TRIALS trial_result · 2022-10-17Clinical Trial Update: HAIC+Lenvatinib+Tislelizumab vs D-TACE+Lenvatinib+Tislelizumab for Unresectable HCC [Phase 2]
Phase 2 trial comparing HAIC+Lenvatinib+Tislelizumab to D-TACE+Lenvatinib+Tislelizumab for unresectable hepatocellular carcinoma is ongoing …
-
CLINICAL_TRIALS trial_result · 2022-10-17Clinical Trial Update: Envafolimab, Lenvatinib Combined With TACE in the Treatment of Unresectable Locally Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of Envafolimab and Lenvatinib with TACE for unresectable locally advanced hepatocellular…
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: TACE Combined With Sorafenib and Tislelizumab for Advanced HCC [Phase 2]
Phase 2 trial update evaluating the combination of TACE with sorafenib and tislelizumab for advanced non-resectable hepatocellular carcinoma…
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: Thermal Ablation Followed by Immunotherapy for HCC [Phase 1, Phase 2]
Clinical trial update exploring thermal ablation followed by immunotherapy for non-resectable hepatocellular carcinoma in Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2022-09-26Clinical Trial Update: TACE Combined With Lenvatinib and MWA in the Treatment of Locally Advanced Large Hepatocellular Carcinoma [Phase 2]
Phase 2 trial updating the combination of transarterial chemoembolization (TACE) with lenvatinib and microwave ablation (MWA) for locally ad…
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: TACE Combined With Camrelizumab and Apatinib in the Treatment of Advanced Liver Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of transarterial chemoembolization (TACE) with camrelizumab and apatinib for advanced hepa…
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant lenvatinib combined with transarterial chemoembolization (TACE) for transplant-eligible patien…
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence [Phase 2]
Phase 2 trial investigating donafenib plus tislelizumab as adjuvant therapy for hepatocellular carcinoma at high risk of recurrence.
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC [Phase 2, Phase 3]
A Phase 2/3 clinical trial update evaluating mitomycin C–based HIPEC for hepatocellular carcinoma with peritoneal metastasis following srHCC…
-
CLINICAL_TRIALS trial_result · 2022-09-01Clinical Trial Update: A Study of Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC) [Phase 3]
A Phase 3 trial evaluating camrelizumab plus rivoceranib mesylate versus investigator's choice in advanced hepatocellular carcinoma was term…
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib Treatment [Phase 2]
A phase 2 trial evaluating gemcitabine with oxaliplatin (GEMOX) in patients with advanced unresectable hepatocellular carcinoma after sorafe…
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating stereotactic ablative radiotherapy for oligometastatic hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC [Phase 2]
Phase 2 clinical trial evaluating hepatic arterial infusion chemotherapy (HAIC) combined with donafenib and toripalimab for unresectable hep…
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: A Pilot Study of "OncozeneTM" Microspheres for Intra-arterial Delivery of Doxorubicin [Phase 2]
Phase 2 pilot trial evaluating Oncozene microspheres for intra-arterial doxorubicin delivery in hepatocellular cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor [Phase 2]
Phase 2 clinical trial update evaluating the effects of propofol and desflurane on nucleic acids of liver circulating tumor cells in hepatoc…
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib [Phase 2]
Phase 2 trial evaluating pembrolizumab as second-line therapy for advanced hepatocellular carcinoma after sorafenib failure has completed wi…
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: TACE With Dicycloplatin(TP21) in Unresectable HCC [Phase 3]
Clinical trial update for TACE with dicycloplatin (TP21) in unresectable hepatocellular carcinoma (Phase 3) with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: Clinical Recruitment of Patients With First-line Targeted Drug Resistance or Intolerance to Hepatocellular Cancer With PD-1 Inhibitor (Toripalimab,JS001) Detected on the NGS Platform Combined With Anlotinib [Phase 2]
Phase 2 clinical trial exploring first-line combination therapy of toripalimab (PD-1 inhibitor) with anlotinib for hepatocellular carcinoma …